Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
ORGANIZATION
Japan Drug Costs to Remain Flat thru 2025, No Annual Price Cuts Necessary: EFPIA
The Japan pharmaceutical market, or the country’s drug spending, is estimated to level off over the next 10 years, growing at a compound average growth rate of 0.13% between 2013 and 2025, EFPIA Japan Chairman Carsten Brunn said on April…
To read the full story
Related Article
ORGANIZATION
- PhRMA Japan Chief Laments CEA Expansion, Calls for Sweeping Reform
November 20, 2026
- Ex-MHLW Bureau Chief Jo Joins Patient Support Foundation
November 20, 2026
- JPMA, EFPIA Follow PhRMA in Decrying CEA Price Cut Expansion
November 19, 2026
- PhRMA Slams CEA Expansion, Warns It Undermines Japan Growth Strategy
November 17, 2026
- UCB Japan President Kikuchi to Take Helm of EFPIA Japan
November 13, 2026





